期刊文献+

葛芪降糖颗粒对2型糖尿病周围神经病变患者血清8-iso-PGF2α的临床观察 被引量:4

Clinical observation of Geqi Jiangtang granules on serum 8-iso-PGF2a in patients with type 2 diabetic peripheral neuropathy
下载PDF
导出
摘要 [目的]通过观察葛芪降糖颗粒对2型糖尿病周围神经病变患者的临床观察,探讨中医药延缓、治疗糖尿病周围神经病变发生、发展的作用机制。[方法]选取本院2型糖尿病伴周围神经病变,且证属肾虚毒滞型的患者60例,采用中心随机分组为中西医结合治疗组(葛芪降糖颗粒联合甲钴胺)、西药组(甲钴胺),每组30例,8周为1个疗程,观察两组患者治疗前后中医证候积分、密西根评分,并检测血糖、糖化血红蛋白、肌电图、血清8-异前列腺素F2a(8-iso-PGF2α)等指标的变化。[结果]1)中西医结合治疗组能明显降低中医证候积分和密西根评分,临床总有效率优于西药组;2)中西医结合治疗组感觉神经传导速度明显优于西药组;3)中西医结合治疗组血清8-isoPGF2α明显低于西药组。[结论]葛芪降糖颗粒明显改善糖尿病周围神经病变(DPN)患者症状与体征,临床疗效优于单纯西药组,作用机制可能是通过减少血清8-iso-PGF2α。 [Objective] Through the observation of Geqi Jiangtang granules combined with Meeobalamin on type 2 diabetic peripheral neuropathy clinical observation of patients.To explore the mechanism of delaying and treating diabetic peripheral neuropathy by traditional Chinese medicine. [Methods] Sixty patients with type 2 diabetes mellitus complicated with peripheral neuropathy in our hospital, who were proved to be kidney deficiency and toxin stagnation type, which were randomly divided into treatment group (combination of Chinese and Western medicine geqiJiangtang granule combined with Meeobalamin) and Western medicine group (Meeobalamin), 30 eases in each group, 8 weeks for 1 courses.The TCM syndrome score and the Michigan score were observed before and after treatment in two groups, and the changes of blood glucose, glyeosylated hemoglobin, eleetromyogram, serum 8-iso- PGF2 and other indexes were detected. [Results] 1) Integrated traditional Chinese and Western medicine treatment group can significantly reduce the TCM syndrome score and the Michigan score, the total effective rate is better than the western medicine group. 2) The sensory nerve conduction velocity in the integrative medicine group was significantly better than that in the western medicine group. 3) The serum 8-iso-PGF2 level in the integrative medicine group was significantly lower than that in the western medicine group. [Conclusion] Geqi Jiangtang granules combined with meeobalamin significantly improve the symptoms and signs of patients with DPN, The clinical curative effect is better than the westernmedieine group. The mechanism of action may be by reducing serum 8-iso-PGF2 alpha.
作者 肖若然 娄锡恩 王帅 XIAO Ruoran;LOU Xien;WANG Shuai(Beijing University of Chinese Medicine Third Affiliated Hospital,Beijing 100029,China)
出处 《天津中医药大学学报》 CAS 2018年第4期283-286,共4页 Journal of Tianjin University of Traditional Chinese Medicine
基金 北京中医药大学自主选题资助项目(J20130756)
关键词 DPN 葛芪降糖颗粒 8-ISO-PGF2Α 补肾活血解毒法 DPN Geqi Jiangtang granules 8-iso-PGF2 alpha Bushen Huoxue Jiedu method
  • 相关文献

参考文献3

二级参考文献24

  • 1Davies M,Brophy S,Williams R. The prevalence,severity,and impact of painful diabetic peripheral neuropathy in type 2 diabetes[J].Diabetes Care,2006,(07):1518-1522.doi:10.2337/dc05-2228.
  • 2Van Acker K,Bouhassira D,De Bacquer D. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics[J].Diabetes & Metabolism,2009,(03):206-213.
  • 3ArgoffCE,Cole BE,Fishbain DA. Diabetic peripheral neuropathic pain:clinical and quality-of-life issues[J].Mayo Clinic Proceedings,2006,(04):3-11.
  • 4Veves A,Backonja M,Malik RA. Painful diabetic neuropathy:epidemiology,natural history,early diagnosis,and treatment options[J].Pain Medicine,2008,(06):660-674.doi:10.1111/j.1526-4637.2007.00347.x.
  • 5Casellini CM,Vinik AI. Clinical manifestations and current treatment options for diabetic neuropathies[J].Endocrine Practice,2007,(05):550-566.doi:10.4158/EP.13.5.550.
  • 6Kawamura N,Dyck PJ,Schmeichel AM. Inflammatory mediators in diabetic and non-diabetic lumbosacral radiculoplexus neuropathy[J].Acta Neuropathologica,2008,(02):231-239.doi:10.1007/s00401-007-0326-2.
  • 7Dyck P J,Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies:new insights into pathophysiology and treatment[J].Muscle and Nerve,2002,(04):477-491.doi:10.1002/mus.10080.
  • 8Kawamura N,Dyck PJ,Schmeichel AM. Inflammatory mediators in diabetic and non-diabetic lumbosacral radiculopleaus neuropathy[J].Acta Neuropathologica,2008,(02):231-239.doi:10.1007/s00401-007-0326-2.
  • 9Thaisetthawatkul P,Dyck PJ. Treatment of diabetic and nondiabetic lumbosacral radiculoplexus neuropathy[J].Current Treatment Options in Neurology,2010,(02):95-99.doi:10.1007/s11940-010-0059-8.
  • 10Hirai A,Yasuda H,Jokp M. Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves[J].Journal of the Neurological Sciences,2000,(01):55-62.doi:10.1016/S0022-510X(99)00290-7.

共引文献13

同被引文献49

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部